OBJECTIVE The objective of this study was to detect fetal exposure to nonsteroidal antiinflammatory drugs (NSAIDs) by meconium analysis and to determine the relationship between fetal exposure to NSAIDs and the development of persistent pulmonary hypertension of the newborn (PPHN). METHODS In a case-control study of the inborn and outborn nurseries of a large urban medical center, meconium wa...

Background: HELLP is an acronym which describes the presence of haemolysis, elevated liver enzymes, low platelet count during pregnancy. It a life-threatening manifestation pre-eclampsia. The incidence syndrome 0.5-0.9% all pregnancies and 10-20% in cases rationale this study lied anticipation that knowledge Syndrome will incite interest medical fraternity handling various pregnancy related com...

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps p...

Background : Presence of meconium in amniotic fluid is potentially a serious sign fetal compromise and associated with an increased perinatal mortality morbidities.Meconium stained considered harbinger because its direct correlation distress likelihood aspiration resultant deleterious effects on the neonatal lung. The purpose study was to find outcome pregnancy staining fluid. Outcome variable ...

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps p...

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps p...

BACKGROUND The oxygenation index (OI = mean airway pressure, MAP × FiO2 × 100 : PaO2) is used to assess the severity of hypoxic respiratory failure (HRF) and persistent pulmonary hypertension of the newborn (PPHN). An indwelling arterial line or arterial punctures are necessary to obtain PaO2 for the calculation of OI. Oxygenation can be continuously and noninvasively assessed using pulse oxime...